Showing results (71-80 of 781) with videos related to
Sort By:
Pageof 79
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Multiple myeloma: new uses for available agents, excitement for the futureKenneth C AndersonSeminars in Oncology|April 1, 2005
Clinical update: novel targets in multiple myelomaKenneth C AndersonJournal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Therapeutic advances in relapsed or refractory multiple myelomaKenneth C AndersonSeminars in Hematology|December 14, 2005
Lenalidomide and thalidomide: mechanisms of action--similarities and differencesKenneth C AndersonExperimental Hematology|March 24, 2007
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactionsKenneth C AndersonCancer Treatment and Research|October 4, 2016
Vision Statement for Multiple Myeloma: Future DirectionsKenneth C AndersonCancer Research|December 3, 2004
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myelomaLaurence Catley, Yu-Tzu Tai, Reshma Shringarpure, et al.Cancer Research|February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myelomaKlaus Podar, Marc S Raab, Giovanni Tonon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
Significant biological role of sp1 transactivation in multiple myelomaMariateresa Fulciniti, Samir Amin, Puru Nanjappa, et al.Pageof 79